Article
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies
2 Jan 2024
Abstract excerpt
Background: The effect of chemoradiation on the anti-cancer immune response is being increasingly acknowledged; however, its clinical implications in treatment responses are yet to be fully understood. Human papillomavirus (HPV)-driven malignancies express viral oncogenic proteins which may serve as tumor-specific antigens and represent ideal candidates for monitoring the peripheral T-cell receptor (TCR) changes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
